Oryzon Genomics (MEX:ORYN) OCF Margin %: 0.00% (As of Mar. 2026)


MEX:ORYN Oryzon Genomics SA MEX:ORYN
31 GF Score
Price MXN48.59
View Full Analysis

What is Oryzon Genomics OCF Margin %?

Oryzon Genomics MEX:ORYN 31 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates MEX:ORYN with a GF Score™ of 31/100. Among 960 Biotechnology companies, Oryzon Genomics ranks worse than 104166.56% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Oryzon Genomics's Cash Flow from Operations for the three months ended in Mar. 2026 was MXN0.00 Mil. Oryzon Genomics's Revenue for the three months ended in Mar. 2026 was MXN0.00 Mil. Therefore, Oryzon Genomics's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Oryzon Genomics's current OCF Yield % is -0.97%.

The historical rank and industry rank for Oryzon Genomics's OCF Margin % or its related term are showing as below:


During the past 12 years, the highest OCF Margin % of Oryzon Genomics was -681.04%. The lowest was -28076.47%. And the median was -14378.76%.

MEX:ORYN's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Oryzon Genomics OCF Margin % Related Terms

Oryzon Genomics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Oryzon Genomics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oryzon Genomics OCF Margin % Chart

Oryzon Genomics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Oryzon Genomics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:ORYN
31GF Score
Oryzon Genomics SA MEX:ORYN
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oryzon Genomics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Oryzon Genomics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-49.84/0
= %

Oryzon Genomics's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Oryzon Genomics (MEX:ORYN) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Oryzon Genomics and its competitors. According to the industry distribution chart, Oryzon Genomics ranks #999999 out of 960 companies in the Biotechnology industry.
Is Oryzon Genomics' OCF Margin % too high?
Oryzon Genomics' current OCF Margin % is 0.00%. Based on the distribution chart, Oryzon Genomics ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Oryzon Genomics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Oryzon Genomics' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oryzon Genomics ranks #999999 out of 960 companies for OCF Margin %. This places Oryzon Genomics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Oryzon Genomics and its competitors. Oryzon Genomics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oryzon Genomics stock overvalued right now?
Oryzon Genomics (MEX:ORYN) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Oryzon Genomics' overall GF Score™ is 31/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Oryzon Genomics (MEX:ORYN), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oryzon Genomics Business Description

Address Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.
31GF Score

Get the complete analysis for MEX:ORYN

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN48.59
Price